A meta-analysis conducted by Dai et al. revealed that HE4 is a good prognostic factor not only for patients with endometrial cancer, but also those suffering from ovarian, lung, and gastric cancer [31,32]. This evidence concerns the gene WFDC2 and endometrial cancer.